PUMA BIOTECHNOLOGY, INC. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q3 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Puma Biotechnology, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q3 2017 to Q3 2024.
  • Puma Biotechnology, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2024 was $54.6M, a 88.6% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.